Key points are not available for this paper at this time.
as a therapeutic agent for liver diseases, presenting a novel approach for dual targeting with a simple conventional siRNA structure.
Ueda et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: